49 studies found for:    Open Studies | MRSA
Show Display Options
Rank Status Study
21 Recruiting Impact of Rapid Detection of MRSA
Condition: Staphylococcus Aureus Infections
Intervention:
22 Unknown  Prospective Evaluation of a Vancomycin Nomogram With a Continuous Infusion of Vancomycin for Surgical ICU Patients
Condition: MRSA - Methicillin Resistant Staphylococcus Aureus Infection
Interventions: Drug: Vancomycin continuous infusion;   Drug: Vancomycin intermittent dosing interval
23 Unknown  Vascular Surgical Antibiotic Prophylaxis Study (VSAPS 2)
Condition: MRSA - Methicillin Resistant Staphylococcus Aureus Infection
Intervention: Drug: Antibiotic Prophylaxis
24 Unknown  Hospital Design and Risk of Nosocomial Infections: A Prospective Controlled Trial
Conditions: Hospital-Acquired Infection With Clostridium Difficile;   Hospital-Acquired VRE Infection or Colonization;   Hospital-Acquired MRSA Infection or Colonization
Intervention: Other: Admission to a novel hospital ward
25 Recruiting Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) Infections
Condition: Skin Diseases, Infectious
Interventions: Drug: Tedizolid(BAY1192631);   Drug: Linezolid
26 Recruiting Aerosolized Vancomycin in Methicillin-Resistant Staphylococcus Aureus Pneumonia Under Mechanical Ventilation
Conditions: Pneumonia, Staphylococcal;   Methicillin-Resistant Staphylococcus Aureus
Intervention: Drug: Vancomycin
27 Not yet recruiting Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA
Conditions: Methicillin-Resistant Staphylococcus Aureus;   Bacterial Infections;   Staphylococcal Skin Infections
Interventions: Drug: Dalbavancin single dose;   Drug: Dalbavancin two dose;   Drug: Comparator
28 Recruiting Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia
Condition: Staph Aureus Methicillin Resistant Bacteremia
Interventions: Drug: Fosfomycin 2gr/6h iv;   Drug: Daptomycin 10mg/kg/24h iv
29 Not yet recruiting Staphylococcus Aureus Resistant to Methicillin (MRSA) Screening in Trauma
Condition: Emergencies
Intervention: Device: GeneXpert®
30 Recruiting Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)
Condition: Cystic Fibrosis
Interventions: Drug: Inhaled Vancomycin;   Drug: Placebo (Sterile Water);   Drug: Rifampin;   Drug: Trimethoprim/Sulfamethoxazole (TMP/SMX);   Drug: Doxycycline;   Drug: Mupirocin Intranasal Creme;   Drug: 4% chlorhexidine gluconate liquid skin cleanser
31 Unknown  Community-Acquired Methicillin Resistant Staphylococcus Aureus Colonization in Pregnant Women and Infections in Newborns
Condition: Staphylococcus Aureus Infection
Intervention: Other: CA-MRSA Decolonization
32 Unknown  Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community
Conditions: ESBL Infection;   Methicillin-Resistant Staphylococcus Aureus
Intervention:
33 Recruiting New Mexico Honey Wound Treatment Research Study
Condition: Community-acquired Methicillin-resistant Staphylococcus Aureus Infection
Interventions: Drug: New Mexico Honey;   Drug: Bactrim DS
34 Unknown  Experimental Phage Therapy of Bacterial Infections
Condition: Bacterial Infections
Intervention: Other: Bacteriophage preparation
35 Recruiting Pharmacokinetic and Pharmacodynamic Evaluation of Linezolid Administered Intravenously in MRSA-positive, Morbidly Obese Patients With Pneumonia
Condition: Pneumonia
Intervention: Drug: Linezolid
36 Not yet recruiting PCR to Guide Antibiotic Therapy for Pneumonia
Conditions: Pneumonia;   Methicillin-Resistant Staphylococcus Aureus
Intervention: Other: Polymerase Chain Reaction (PCR)
37 Unknown  Prevention of Gastrostomy-Related Wound Infection by Vancomycin in Carriers of Methicillin-Resistant Staphylococcus Aureus.
Condition: Wound Infection
Intervention: Drug: Vancomycin
38 Unknown  Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community-Healthcare Workers
Conditions: Methicillin-Resistant Staphylococcus Aureus;   ESBL
Intervention:
39 Recruiting Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant
Conditions: Bacterial Infection;   Benign Neoplasm;   Malignant Neoplasm;   Methicillin-Resistant Staphylococcus Aureus Infection;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Untreated Childhood Myeloid Neoplasm
Interventions: Drug: Chlorhexidine Gluconate;   Procedure: Wound Care Management;   Other: Questionnaire Administration;   Other: Laboratory Biomarker Analysis
40 Recruiting The Use of Ceftaroline as Surgical Prophylaxis in Surgery With Risk of MRSA Infection
Condition: Surgical Site Infection
Interventions: Drug: Ceftaroline;   Drug: Cefazolin / Vancomycin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-49) Show next page of results    Last Page
Indicates status has not been verified in more than two years